Organon stock cut their dividend by over 90%. There are lessons here for all income investors. Click here to find out what ...

Shares of Organon (NYSE:OGN) plunged ~13% in the premarket on Thursday after the company, with its Q1 2025 financials, ...

Pharmaceutical company Organon (NYSE:OGN) reported in Q1 CY2025, but sales fell by 6.7% year on year to $1.51 billion. Its ...

BofA analyst Jason Gerberry lowered the firm’s price target on Organon (OGN) to $10 from $11 and keeps an Underperform rating ...

Organon was hurt in Q4/2024 by flat year-over-year sales. The company saw a 37% decline (excluding foreign exchange) in ...

The Jersey City, N.J., pharmaceutical company cut its quarterly dividend to 2 cents a share, down from the prior 28 cents a share. Chief Executive Kevin Ali said the company reset its ...

Organon & Co. advanced stock charts by Barron's. View OGN historical stock data and compare to other stocks, and exchanges.

The DJS Law Group announces that it is investigating claims on behalf of investors of Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the securities laws.

Jennifer Halchak; VP, IR; Organon & Co. Kevin Ali; Chief Executive Officer, Director; Organon & Co. Matthew Walsh; Chief Financial Officer, Senior Vice President; Or ...

The Jersey City, New Jersey-based company said it had net income of 33 cents per share. Earnings, adjusted for one-time gains and costs, were $1.02 per share. The results topped Wall Street ...

Organon reaffirmed its full-year 2025 revenue guidance of $6.125-6.325 billion, with the midpoint slightly below the consensus estimate of $6.292 billion. The company also expects to generate over ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Thursday reported first-quarter net income of $87 million. The Jersey City, New Jersey-based company said it had net ...